-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
-
Summary
-
Kairos Pharma, LTD. quarterly Preferred Stock, Shares Authorized history and change rate from Q1 2023 to Q3 2025.
- Kairos Pharma, LTD. Preferred Stock, Shares Authorized for the quarter ending 30 Sep 2025 was 20,000,000, unchanged year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Change (%)